Low molecular weight non-peptide mimics of ω-conotoxin GVIA

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 10, 2009, Pages 2763-2765

  Duggan, Peter J ^a   Lewis, Richard J ^b   Phei Lok, Y ^a   Lumsden, Natalie G ^b   Tuck, Kellie L ^c   Yang, Aijun ^b  

^a CSIRO   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Calcium channel blocker; Conotoxin; GVIA; Pain; Peptidomimetic

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; CALCIUM CHANNEL N TYPE; OMEGA CONOTOXIN GVIA;

ARTICLE; CONCENTRATION RESPONSE; DRUG BINDING SITE; DRUG DESIGN; DRUG SYNTHESIS; HYDROGEN BOND; MOLECULAR INTERACTION; MOLECULAR WEIGHT;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; MOLECULAR WEIGHT; OMEGA-CONOTOXIN GVIA; RATS;

EID: 65349092329     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.03.130     Document Type: Article

References (21)

1. Morishita M., and Peppas N.A. Drug Discovery Today 11 (2006) 905
2. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Adv. Drug Delivery Rev. 23 (1997) 3
3. Olivera B.M. J. Biol. Chem. 281 (2006) 31173
4. Schroeder C.I., Doering C.J., Zamponi G.W., and Lewis R.J. Med Chem. 2 (2006) 535
5. McGivern J.G. Drug Discovery Today 11 (2006) 245
6. Miljanich G.P. Curr. Med. Chem. 11 (2004) 3029
7. Ellis D.J., Dissanayake S., McGuire D., Charapata S.G., Staats P.S., Wallace M.S., Grove G.W., and Vercruysse P. Elan Study 95-002 Group, Neuromodulation 11 (2008) 40
8. Lynch S.S., Cheng C.M., and Yee J.L. Ann Pharmacother. 40 (2006) 1293
9. Staats P.S., Yearwood T., Charapata S.G., Presley R., Wallace M.S., Byas-Smith M., Fisher R., Bryce D.A., Mangieri E.A., Luther R.R., Mayo M., McGuire D., and Ellis D. J. Am. Med. Assoc. (2004) 63
10. Wermeling D., Drass M., Ellis D., Mayo M., McGuire D., O'Connell D., Hale V., and Cho S. J. Clin. Pharma. (2003) 624
11. Dabak K. Turk. J. Chem. 26 (2002) 955
12. Menzler S., Bikker J.A., and Horwell D.C. Tetrahedron Lett. 39 (1998) 7619
13. Menzler S., Bikker J.A., Suman-Chauhan N., and Horwell D.C. Bioorg. Med. Chem. Lett. 10 (2000) 345
14. http://www.contractpharma.com/news/2007/08/08/neuromed%2c_merck_discontinue_pain_drug_candidate. Accessed 20 July 2008.
15. Cao Y.-Q. Pain 126 (2006) 5
16. http://www.neuromed.com, Accessed 1 Sept 2008.
17. Baell J.B., Duggan P.J., Forsyth S.A., Lewis R.J., Lok Y.P., and Schroeder C.I. Bioorg. Med. Chem. 12 (2004) 4025
18. Baell J.B., Duggan P.J., Forsyth S.A., Lewis R.J., Lok Y.P., and Schroeder C.I. Tetrahedron 62 (2006) 7284
19. Baell J.B., Duggan P.J., and Lok Y.P. Aust. J. Chem. 57 (2004) 179
20. Duggan P.J., Faber J.M., Graham J.E., Lewis R.J., Lumsden N.G., and Tuck K.L. Aust. J. Chem. 61 (2008) 11
21. Baell J.B., Forsyth S.A., Gable R.W., Norton R.S., and Mulder R.J. J. Comput. Aided Mol. Des. 15 (2001) 1119